UK-279276

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUK-279276
Drug Alias NamerNIFCorleukin NIFRecombinant neutrophil inhibitory factor
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionIntegrin alpha-M/beta-2 antagonists
TargetsIntegrin alpha-M/beta-2
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego Llc
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A